The oltipraz pretreatment significantly upregulated the expression levels of miR338-3p in HFLS (p<0.05,vs.HFLS group), and the effects of oltipraz on miR338-3p was reversed by Lv-shRNA-Nrf2 infection in HFLS (p<0.01,vs.HFLS + oltipraz group) (Fig. 3-D). Here, NFE2L2 is linked to infection.